This grant supports research projects investigating real world evidence on the impact of early and appropriate use of Aztreonam-Avibactam (ATM-AVI). Funded studies may be conducted in Australia, Brazil, Chile, India, Italy, South Africa, Spain, and the United Kingdom. The review process is internal to Pfizer.
Eligibility criteria are not specified for this funding opportunity.
